Keywords: Diabetes drugs, US R&D pipeline, PhRMA, Cost of diabetes care

More than 220 medicines in US pipeline for diabetes

Article | 13 November 2012

America’s biopharmaceutical research companies currently are developing 221 innovative new medicines to help the nearly 26 million patients in the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in